research Vascular Targeting for Botulinum Toxin Pain Injections
Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.
Search
for
Sort by
Research
570-600 / 1000+ results 
research Botulinum Toxin A in the Treatment of Facial Reflex Sympathetic Dystrophy: A Case Report
Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.
research The Use of Botulinum Toxin in the Treatment of Male Pattern Baldness
Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.
research Testosterone Enantate Induced Androgenetic Alopecia in a 46XX True Hermaphrodite
A man developed hair loss from testosterone treatment but improved with additional medication.
research The Association Between Male Pattern Baldness and Second to Fourth Finger Ratio with Prostate Cancer: A Prospective Cohort Study
Male pattern baldness may predict prostate cancer risk.
research Hair Transplantation: Causes, Techniques, and Future Prospects
Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.
research Clinical Review of Androgenic Alopecia (7th Report)
More men have androgenic alopecia than women, with stress linked to the condition in both genders.
research Original Article: Clinical Review of Androgenic Alopecia (7th Report)
The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.
research Surgical Reduction of Alopecia
Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.
research Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-Sectional Observational Study
Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.
research Asymmetry of the Receding Hairline in Men With Early Androgenetic Alopecia
Receding hairlines in men are uneven, with the right side larger than the left.
research Androgenetic Alopecia
Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.
research Classifications of Patterned Hair Loss: A Review
Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.
research Diagnosis of Hair Disorders
The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.
research The Effects of Minoxidil, 1% Pyrithione Zinc, and a Combination of Both on Hair Density: A Randomized Controlled Trial
Minoxidil and pyrithione zinc combo most effectively increases hair density.
research Androgenetic Alopecia and Insulin Resistance in Young Men
Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.
research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
research Validity of Self-Reported Male Balding Patterns in Epidemiological Studies
Men can report their own balding patterns well enough for large health studies.
research Does Degree of Baldness Influence Vitamin D Status?
Baldness does not affect vitamin D levels in men.
research Evaluation of the Expression of Genes Associated with Inflammation and Apoptosis in Androgenetic Alopecia by Targeted RNA-Seq
WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.
research Male Balding as a Major Risk Factor for Severe COVID-19: A Possible Role for Targeting Androgens and Transmembrane Protease Serine 2 to Protect Vulnerable Individuals
Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.
research Male Pattern Androgenetic Alopecia
Androgens contribute to common male hair loss; more research needed for hair growth medication.
research Male Pattern Baldness: Psychological Impact, Disease Association, and Treatment Options
Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.
research Histopathological Evidence of Occipital Involvement in Male Androgenetic Alopecia
Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.
research Alopecia and Microbiome: Future Therapeutic Target?
The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.
research Is There a Relationship Between Androgenic Alopecia and Benign Prostatic Hyperplasia?
There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.
research Reply to: Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
research The Relation Between Androgenetic Thin Hair Diagnosed by Trichoscope and Benign Prostatic Hyperplasia
Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.
research Telogen Hair Loss and Androgenetic-Like Alopecia in GAPO Syndrome
A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.
research Microstrip Technique in Follicular Unit Extraction
The microstrip technique for hair transplantation is effective and discreet for patients needing fewer than 1500 grafts.